Industry Experts

Caitlyn Krebs is a life sciences executive and recognized expert in the endocannabinoid system, with 20+ years building and scaling companies across biotech, diagnostics, and digital health. She's led startups spanning diabetes, Alzheimer's, cancer, and ML/AI, closing 50+ B2B deals across both B2B and DTC launches. As Co-Founder & CEO of Nalu Bio, Caitlyn leads an AI-driven Endocannabinoid Discovery Platform that applies a GLP-1-style approach to CB1/CB2 receptor targeting — spanning meld, an AI-powered women's wellness brand, and a pipeline of prescription therapeutics for women's health. Previously, Caitlyn was CBO of a genomics company focused on early cancer detection, COO of Neurotrack (digital health for cognitive decline and Alzheimer's), and VP of Business Development at Rock Health. She holds a BS in Biology from Brown University, where she graduated with honors.